The global demand for Nicotine Replacement Therapy Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2020- 2026.
Nicotine replacement therapy (NRT) is the first pharmacological drug that was approved by the FDA for smoking cessation. Nicotine replacement therapy aims to reduce withdrawal symptoms which are often experienced during an attempt to quit smoking and thus increase the probability of remaining abstinent. Nicotine gums were the first product that was introduced in the early '80s followed by the nicotine patch in the early '90s and both became available over the counter (OTC) after few years. Then nicotine nasal spray was introduced by prescription, followed by the nicotine inhaler in the same year and now both them are available over the counter. Nicotine longezes/tablets were introduced, later on, they come in pill or candy-like tablet and are also available OTC. All these forms of delivery can be purchased by anyone at pharmacies, drug stores, and supermarkets.
The market of NRT is driven by the growing desire to quit smoking and the rising number of manufacturers offering anti-smoking campaigns and penetration of smoking cessation products. Other factors like growing cases of chronic obstructive pulmonary disease (COPD), asthma, lung cancer, asthma, various cardiac and respiratory disease coupled with rising awareness regarding negative effects of smoking is also set to support the market expansion over the forecast period.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of nicotine replacement therapy.
The entire nicotine replacement therapy market has been sub-categorized into product type and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product Type
By Distribution Channel
- Nasal Spray
- Sublingual Tablets
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
This section covers regional segmentation which accentuates on current and future demand for nicotine replacement therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Nicotine Replacement Therapy Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the nicotine replacement therapy market include Pfizer, Inc., Novartis International AG, Takeda pharmaceutical Company Ltd., Cipla Ltd., McNeil AB, Revolymer PLC, NJOY, Inc., VMR products, LLC, Imperial Tobacco Ltd., GlaxoSmithKline plc, Fertin Pharma, and Glenmark Pharmaceuticals Limited. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.